The Strategic Role of Basic Research Payments in the Massachusetts Research and Development Tax Incentive Framework

Basic Research Payments (BRP) within the Massachusetts tax code represent specialized expenditures made to qualified academic or scientific institutions for fundamental research that lacks specific commercial goals. Under M.G.L. c. 63 § 38M, these payments qualify for a robust 15% tax credit on amounts exceeding a historical base period threshold, fostering deep collaboration between the Commonwealth’s private sector and its world-tier research universities.1

The Massachusetts Research and Development (R&D) Tax Credit is one of the most significant fiscal instruments utilized by the Commonwealth to maintain its position as a global leader in innovation, particularly in the biotechnology, life sciences, and defense sectors.4 While the 10% credit for qualified research expenses (QREs) covers the majority of in-house technological development, the 15% tier for Basic Research Payments (BRP) serves as a targeted catalyst for foundational science.3 This mechanism operates through a sophisticated integration of state law and the federal Internal Revenue Code (IRC), specifically adopting the definitions of IRC § 41 as they stood on August 12, 1991, for its traditional calculation method.3 The following analysis explores the statutory definitions, regulatory guidance from the Department of Revenue (DOR), and the complex mathematical hurdles—such as the Maintenance of Effort (MOE) requirement—that corporations must navigate to successfully claim this high-value incentive.10

Statutory Foundations and the Evolution of M.G.L. c. 63 § 38M

The legal architecture of the Massachusetts Research Credit is primarily governed by M.G.L. c. 63 § 38M, a statute designed to parallel the federal research credit while maintaining distinct geographic and administrative boundaries.1 Since its inception, the credit has undergone several rounds of modernization to reflect the changing nature of corporate innovation and the lifecycle of startups within the state’s ecosystem.11 The statute provides a nonrefundable credit against the corporate excise tax for corporations that either incur qualified research expenses or make basic research payments within the state’s borders.4

Historical context is vital for understanding the current application of the law. For decades, the Massachusetts credit was tethered to a “traditional method” that required extensive historical data reaching back to the mid-1980s to establish a base amount.9 However, the enactment of St. 2014, c. 287 and St. 2014, c. 359 introduced the Alternative Simplified Method (ASM), providing an easier path for newer companies and financial institutions to access these benefits.12 Despite these updates, the 15% BRP component remains a cornerstone of the traditional method, incentivizing long-term investments in the state’s academic infrastructure.1

The Geographic Limitation Mandate

A defining characteristic of the Massachusetts credit, which distinguishes it from its federal counterpart, is the strict requirement for in-state activity.1 To qualify for either the 10% or 15% credit, the research must be conducted physically within the Commonwealth.10 This is particularly relevant for Basic Research Payments made to universities; if a Massachusetts-based corporation funds a project at an out-of-state university, those payments do not qualify for the state credit, regardless of their eligibility for the federal credit.10

For mobile workforces or multi-state research facilities, the Department of Revenue requires a meticulous proration of expenses.10 This proration is based on the ratio of the number of days the service provider or property was used in Massachusetts compared to the total number of days employed in the research activity.10 This regulation ensures that the tax benefit remains directly tied to the economic and scientific output generated within state lines.14

Defining Basic Research and Qualified Recipients

The definition of “Basic Research” under M.G.L. c. 63 § 38M is borrowed from the federal guidelines but applied within the state’s regulatory vacuum.1 “Basic research” is defined as any original investigation for the advancement of scientific knowledge not having a specific commercial objective.2 This distinguishes it from “Applied Research,” which is often aimed at a specific product or process improvement and falls under the 10% QRE category.2

Criteria for Qualified Organizations

To receive a 15% credit, the payments must be directed to specific types of “qualified organizations”.2 The law limits this to four primary categories of entities, ensuring that the funds support institutions dedicated to public scientific advancement rather than private commercial gain.7

These payments must be made pursuant to a written agreement between the corporation and the qualified organization.7 The agreement must be entered into prior to the performance of the research, and the corporation must bear the financial risk of the research failing.18 This “risk of failure” clause is a critical audit point; if the contract guarantees a specific commercial result or protects the corporation from loss, the DOR may reclassify the payment as a service contract rather than a basic research payment.18

The 15% Credit Calculation: Determining the Incremental Excess

The 15% credit for BRP is not applied to the total amount paid to a university; rather, it is applied to the amount by which current-year payments exceed a specific “base period” threshold.1 This threshold, known as the “qualified organization base period amount,” is the sum of two components: the Minimum Basic Research Amount and the Maintenance of Effort (MOE) amount.10

Minimum Basic Research Amount (MBRA)

The MBRA is generally calculated as 50% of the average of the basic research payments made during the base period.10 For many corporations, the base period is defined by their activity in the years preceding the implementation of the credit program.1 If a corporation is a “start-up” or has no history of such payments, the law provides fallback percentages to ensure the base is not artificially low, which would otherwise provide an unintended windfall.9

The Maintenance of Effort (MOE) Safeguard

The MOE amount is an anti-abuse provision unique to the BRP calculation.10 Its purpose is to prevent corporations from simply recharacterizing their existing charitable donations to universities as “basic research payments” to claim the 15% credit.10 The MOE ensures that the credit only applies to new or increased research spending above and beyond the corporation’s historical level of non-research giving.10

The Maintenance of Effort is calculated using the following formula:

$$MOE = (Average\ Base\ Period\ Nondesignated\ Contributions \times COLA) – Current\ Year\ Nondesignated\ Contributions$$

Where:

• Nondesignated Contributions: Cash contributions to a qualified organization that were not treated as BRP or QRE.7
• COLA: The cost-of-living adjustment as defined by Section 41(e)(5)(C) of the Code.10

If a corporation significantly reduces its general giving to a university while claiming a large research credit, the MOE will increase, raising the base and effectively reducing the available credit.10 This regulatory nuance requires tax departments to coordinate closely with corporate philanthropy and foundations to avoid inadvertently cannibalizing tax credits through changes in charitable strategy.10

Local State Revenue Office Guidance: 830 CMR 63.38M.1 and.2

The Massachusetts Department of Revenue (DOR) provides the primary interpretive guidance for the R&D credit through its regulations and Technical Information Releases (TIRs).13 There is a dual-track regulatory environment: 830 CMR 63.38M.1 governs periods before 2015, while 830 CMR 63.38M.2 (currently in proposed form) governs periods from 2015 onward.10

Enforcement of Proposed Regulations

Although 830 CMR 63.38M.2 remains technically “proposed,” it is functionally the law of the land for current tax filers.11 The DOR has explicitly stated in TIR 25-3 that it will not enforce certain restrictive portions of the proposed regulation that previously prevented corporations from electing the ASM on an amended return.15 This pivot follows a landmark 2024 Appellate Tax Board decision that opened the research credit to financial institutions, signaling a more inclusive approach to what constitutes “innovation” in the modern economy.4

Accounting Rules and Consistency

The DOR requires corporations to use the same method of accounting for the state credit as they use for the federal credit under Section 41.10 This includes the “consistency requirement,” which mandates that the qualified research expenses and basic research payments taken into account in the credit year be determined on a basis consistent with the determination for the base period years.7 If a corporation discovers a new category of eligible expenses today, it must technically adjust its historical base to include those types of expenses, ensuring the credit truly reflects an “increase” in research activity.7

Detailed Example: Calculating the Integrated Research Credit

To visualize the interplay between BRP and QRE, consider “Commonwealth Bio-Systems,” a hypothetical corporation conducting both internal R&D and external university research in Massachusetts for the 2024 tax year.

Financial Assumptions

• Current Year MA QREs: $2,500,000 (Wages, supplies, and contract research).10
• Current Year MA BRPs: $500,000 (Fundamental molecular research at a MA university).2
• QRE Base Amount: $1,500,000 (Calculated using the traditional method).12
• BRP Base Period Amount: $200,000 (Includes MBRA and MOE calculations).10

Step 1: Calculate the QRE Credit Component

The traditional method provides a 10% credit on the excess of qualified research expenses over the base amount.1

$$QRE\ Credit = (Current\ QRE – QRE\ Base) \times 10\%$$

$$QRE\ Credit = (\$2,500,000 – \$1,500,000) \times 0.10 = \$100,000$$

Step 2: Calculate the BRP Credit Component

The traditional method provides a 15% credit on the excess of basic research payments over the base period amount.1

$$BRP\ Credit = (Current\ BRP – BRP\ Base) \times 15\%$$

$$BRP\ Credit = (\$500,000 – \$200,000) \times 0.15 = \$45,000$$

Step 3: Sum the Components for the Total Research Credit

$$Total\ Credit = \$100,000 (QRE) + \$45,000 (BRP) = \$145,000$$

In this scenario, the BRP component contributed over 31% of the total credit value, despite representing only 16% of the total research spend.1 This demonstrates the significant leverage provided by the 15% rate, particularly for companies that maintain stable or slightly increasing university partnerships.1

Limitations on Credit Application and Carryover Provisions

Generating a credit of $145,000 does not necessarily mean the corporation will reduce its tax bill by that full amount in the current year.1 Massachusetts imposes strict limitations on how much credit can be used in a single taxable year to ensure a minimum level of tax revenue is maintained.1

The 75% Rule and the $25,000 Threshold

The credit is limited to 100% of the first $25,000 of corporate excise, plus 75% of the excise in excess of $25,000.1 Furthermore, the credit cannot reduce the excise below the minimum tax of $456.4

Carryforward Rules: Standard vs. Unlimited

If a corporation generates more credit than it can use due to these limitations, the unused portion enters a carryforward status.1

• 15-Year Carryforward: Credits that exceed the current year’s liability can be carried forward for 15 taxable years.8
• Unlimited Carryforward: Any portion of the credit that was disallowed specifically due to the “75% of excise in excess of $25,000” rule can be carried forward indefinitely.4

This indefinite carryforward provision is a powerful tool for large corporations with massive R&D budgets, as it ensures that the “lost” 25% of the credit can eventually be recovered in future years, provided the company remains a going concern.4

Corporate Aggregation and Controlled Group Dynamics

Massachusetts law requires that the research credit be calculated on an “aggregated” basis for groups of corporations under common control.1 This prevents businesses from artificially restructuring their operations into multiple smaller entities to exploit the $25,000 full-credit bracket multiple times.1

The Aggregate Calculation Process

An aggregated group (defined under IRC § 41(f)(1)(A)) must first calculate a single total credit for the entire group as if it were a single taxpayer.1 This involves:

1. Eliminating all inter-company payments between group members to avoid double-counting research expenses.9
2. Summing the qualified research expenses and basic research payments of all members.9
3. Calculating a group-wide base amount using the combined gross receipts and historical data of all members.9

Once the group-wide credit is determined, it is allocated to the individual corporations doing business in Massachusetts.9 This allocation is based on each corporation’s share of the group’s total research expenses and basic research payments.9 This process is highly complex and typically requires specialized tax software or external consultants to ensure that the individual entity-level excise returns (such as Schedule RC) are populated correctly.12

Industry-Specific Implications: Life Sciences and Defense

While the R&D tax credit is available to all industries, the Life Sciences and Defense sectors are the primary beneficiaries of the BRP and specialized refundability rules.5

Refundability for Certified Life Sciences Companies

In a departure from the general “nonrefundable” nature of the research credit, certified life sciences companies may apply for a refund of their excess research credits through the Massachusetts Life Sciences Center (MLSC).4 Under the Life Sciences Tax Incentive Program, companies can elect to receive a 90% refund on the portion of the credit that exceeds their excise liability.6

In 2022, 18 such credits were awarded, totaling over $7.3 million.6 This program is essential for the pre-revenue biotech companies that populate the Cambridge-Boston innovation corridor, as it provides critical non-dilutive capital during the “valley of death” between basic research and FDA approval.5

Defense-Related Activities Carve-Out

Subsection (i) of § 38M allows a taxpayer to separate its research activities into “defense-related” and “other” categories.1 This election allows a defense contractor to calculate a credit for its military work independently of its commercial projects, potentially yielding a higher total credit if the base periods for the two divisions differ significantly.1

The definition of “defense-related activities” was expanded in 2024 to reflect modern biological and chemical security needs.9 It now includes 9:

• Arms, ammunition, or implements of war designated in the US Munitions List.
• Medicines and medical supplies used to treat or prevent diseases related to chemical, biological, radiological, or nuclear threats.
• Biologic products, vaccines, blood products, and antibodies.

This expansion ensures that the 15% BRP credit can be applied to fundamental immunological research that serves both public health and national security interests.9

Economic Impact and Legislative Trends

The Massachusetts Research Credit represents a substantial investment of state resources. According to the Fiscal Year 2025 Tax Expenditure Budget, the Commonwealth expects to forgo over $644 million in revenue to support this program.16

Statistics on Credit Growth

The steady increase in expenditures (averaging a 10% annual growth rate) underscores the increasing R&D intensity of the Massachusetts economy.16 However, this growth also invites greater scrutiny from the Department of Revenue and the legislature regarding the “Return on Investment” (ROI) of these credits, leading to more frequent audits and the implementation of transparency reports.6

Administrative Compliance and Documentation Requirements

Successfully claiming a 15% BRP credit requires more than just making a payment to a university; it requires a robust “Audit Defense” strategy built on contemporaneous documentation.4 The Department of Revenue has a three-year window for audits, but practitioners recommend maintaining records for seven years to cover base period verifications.4

Essential Documentation Checklist

Corporations should maintain a dedicated “R&D Tax Credit File” containing 17:

• The Basic Research Agreement: A signed, dated contract with the university or research organization detailing the scope of fundamental research and the financial risk allocation.12
• Proof of Massachusetts Activity: Documentation from the university certifying that the research was performed within the state, such as facility addresses or researcher location affidavits.10
• General Ledger Detail: Clear accounting entries for the payments, including proof of cash transfer (BRPs must be paid in cash/check, not in-kind services).7
• Philanthropy Reconciliation: A list of all “nondesignated contributions” made to the same organization to calculate the Maintenance of Effort (MOE) amount.10
• Personnel Role Analysis: For internal support of basic research, a list of employee roles and time-tracking data.17

Failure to provide these records upon request can lead to the “Inadequate Records” penalty, where the DOR sets the corporation’s fixed-base percentage at the maximum of 16%, significantly increasing the base amount and potentially eliminating the credit entirely.10

Interplay with Federal Tax Reform and Section 174

A significant headwind for R&D-intensive companies is the recent change to IRC Section 174 under the Tax Cuts and Jobs Act (TCJA). Historically, R&D expenses could be deducted immediately.5 Starting in 2022, companies are required to capitalize and amortize these costs over 5 years (for domestic research) or 15 years (for foreign research).5

While Massachusetts generally adopts federal definitions, the state’s decoupling from the most recent federal changes in some areas means that companies may face a situation where they are claiming a state tax credit for an expense they are not allowed to fully deduct in the current year for federal purposes.5 This divergence adds a layer of complexity to the “book-to-tax” reconciliation and requires careful planning to manage the resulting deferred tax assets.5

Conclusion: Maximizing the Value of Academic Partnerships

The 15% Basic Research Payment (BRP) credit within the Massachusetts R&D framework is a powerful, if complex, incentive that rewards the Commonwealth’s most forward-thinking corporations.1 By providing a higher credit rate for fundamental science than for applied commercial development, the state effectively subsidizes the risky, long-term exploration that underpins the next generation of breakthroughs.1 However, the efficacy of this credit is contingent upon a corporation’s ability to navigate the nuances of “Qualified Organizations,” the strict in-state activity requirements, and the anti-abuse Maintenance of Effort (MOE) calculations.10

For businesses operating in the life sciences, technology, and defense sectors, the BRP component is more than just a line item on a tax return; it is a strategic tool that facilitates the “Massachusetts Miracle” of academic-corporate synergy.5 As the Department of Revenue continues to modernize its guidance through Proposed Regulation 830 CMR 63.38M.2 and recent TIRs expanding eligibility to financial institutions, the opportunity for collaborative innovation has never been greater.4 Corporations that maintain meticulous records and engage in proactive tax planning will find that the 15% BRP credit offers a substantial competitive advantage, ensuring that their foundational research today translates into a resilient and tax-efficient commercial future.4

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/